Core concept → what it predicts at the bedside
- The blood:gas partition coefficient (λB:G) is the key determinant of how quickly alveolar partial pressure (FA) rises towards inspired partial pressure (FI), and therefore how quickly the brain partial pressure rises.
- Lower λB:G → less uptake into blood for a given alveolar partial pressure → faster rise in FA/FI → faster induction and faster recovery (all else equal).
- Higher λB:G → more uptake into blood → slower rise in FA/FI → slower induction and slower recovery.
- λB:G does not measure potency (that is MAC); it measures solubility in blood relative to gas, which influences kinetics.
Clinical implications you can state in a viva
- Low λB:G agents (e.g. desflurane, sevoflurane, nitrous oxide) give rapid changes in depth and rapid wake-up; high λB:G agents (e.g. isoflurane, halothane) change more slowly.
- When λB:G is high, factors that increase uptake (high cardiac output, high alveolar–venous partial pressure gradient) have a larger slowing effect on FA/FI.
- In low λB:G agents, the system is less uptake-limited; changes in ventilation and delivered concentration translate to faster changes in FA.
Definition and interpretation
- Blood:gas partition coefficient (λB:G) = ratio of concentration of anaesthetic in blood to that in alveolar gas when partial pressures are equal at equilibrium.
- It is a solubility ratio: how much dissolves in blood compared with remaining in gas phase at the same partial pressure.
- Units: dimensionless.
- A practical way to phrase it: λB:G tells you how big the ‘blood reservoir’ is for a given alveolar partial pressure.
Typical values (approximate; order matters more than exact numbers)
- Desflurane: ~0.42
- Nitrous oxide: ~0.47
- Sevoflurane: ~0.65
- Isoflurane: ~1.4
- Halothane: ~2.4
Link to FA/FI and uptake (the standard FRCA explanation)
- Rate of rise of FA/FI is slowed by uptake of agent from alveoli into blood.
- Uptake is increased by: higher λB:G, higher cardiac output, higher alveolar–venous partial pressure gradient, and higher inspired concentration (concentration effect).
- High λB:G increases the amount taken up for a given alveolar partial pressure, so FA rises more slowly.
- Ventilation: increasing alveolar ventilation increases delivery of agent to alveoli and tends to increase FA/FI; this effect is more pronounced for soluble agents (high λB:G) because uptake would otherwise keep FA low.
Determinants of λB:G (what changes it?)
- λB:G depends on solubility in whole blood: plasma solubility + red cell solubility (including binding to proteins/lipids).
- Temperature: increasing temperature generally decreases solubility of gases in liquids → lowers λB:G → faster FA rise (small effect clinically).
- Haematocrit: can alter blood solubility depending on agent’s affinity for RBCs; effect is agent-dependent and usually modest clinically.
- Plasma proteins/lipids: increased lipid content can increase solubility for lipophilic agents; major clinical relevance is limited compared with cardiac output/ventilation effects.
Clinical scenarios: how λB:G interacts with physiology
- High cardiac output (e.g. sepsis, pregnancy, anxiety/pain): increases uptake from alveoli → slows FA/FI rise, especially for high λB:G agents; may need higher delivered concentration to achieve target FA.
- Low cardiac output (e.g. shock): reduces uptake → FA rises faster (risk of rapid deepening); but tissue perfusion is reduced so equilibration to brain may be less predictable.
- Hyperventilation: speeds induction more for soluble agents; less impact for poorly soluble agents where FA already rises quickly.
- Recovery: low λB:G → less blood and tissue storage → faster washout; high λB:G → more storage and slower washout (particularly after long cases due to tissue compartments).
Distinguish from other partition coefficients
- Oil:gas partition coefficient correlates with potency (MAC) via Meyer–Overton; not with speed of onset.
- Brain:blood (or vessel-rich group:blood) partition influences how much agent is required to saturate brain tissue, but λB:G remains the key driver of FA rise and early kinetics.
Define the blood:gas partition coefficient and explain its clinical significance.
Aim: definition + link to FA/FI + induction/recovery.
- λB:G is the ratio of concentration in blood to concentration in alveolar gas when partial pressures are equal at equilibrium.
- It reflects blood solubility: higher λB:G means more dissolves in blood for a given alveolar partial pressure.
- High λB:G increases uptake from alveoli → slows rise of FA/FI → slower induction and slower recovery.
- Low λB:G → minimal blood reservoir → FA rises quickly → rapid changes in depth and rapid wake-up.
Rank common volatile agents by blood:gas solubility and relate this to speed of induction.
You can score well by giving the correct order and a brief consequence.
- Lowest to highest λB:G (typical): desflurane (~0.42) ≈ nitrous oxide (~0.47) < sevoflurane (~0.65) < isoflurane (~1.4) < halothane (~2.4).
- Lower λB:G agents have faster FA/FI rise → faster induction and emergence.
Explain why increasing cardiac output slows induction more with isoflurane than with desflurane.
This is a classic uptake/solubility interaction question.
- Higher cardiac output increases pulmonary blood flow, increasing uptake of anaesthetic from alveoli into blood.
- With a higher λB:G agent (isoflurane), blood can dissolve more agent at a given alveolar partial pressure, so increased flow removes proportionally more agent from alveoli, keeping FA lower and slowing FA/FI rise.
- With a low λB:G agent (desflurane), blood takes up relatively little at a given partial pressure, so the effect of increased flow on FA is smaller.
How does hyperventilation affect the rate of rise of FA/FI for soluble versus insoluble agents?
Expect to compare high vs low λB:G.
- Increasing alveolar ventilation increases delivery of agent to alveoli and tends to increase FA/FI.
- Effect is greater for soluble (high λB:G) agents because uptake would otherwise keep FA low; extra ventilation helps ‘keep up’ with uptake.
- Effect is smaller for insoluble (low λB:G) agents because FA rises quickly even without large changes in ventilation.
A previous-style question: ‘What factors determine the rate of rise of alveolar concentration of an inhalational agent?’ Where does blood:gas partition coefficient fit?
Structure your answer as delivery vs uptake.
- Delivery to alveoli: inspired concentration (vaporiser setting), fresh gas flow/circuit factors, and alveolar ventilation.
- Uptake from alveoli: blood:gas partition coefficient, cardiac output, and alveolar–venous partial pressure gradient.
- λB:G increases uptake for a given FA, slowing the rise of FA/FI and delaying equilibration with brain.
Explain why low blood:gas solubility leads to faster recovery, and when this advantage may be reduced.
Mention tissue storage and duration of anaesthesia.
- Low λB:G means less agent is dissolved in blood at a given partial pressure, so there is less to wash out when you turn the vaporiser off.
- This produces a faster fall in FA and therefore faster fall in brain partial pressure (faster emergence).
- Advantage may be reduced after prolonged cases due to accumulation in tissue compartments (especially fat), and by low alveolar ventilation post-op (hypoventilation).
Differentiate blood:gas partition coefficient from oil:gas partition coefficient.
A common FRCA viva discriminator.
- Blood:gas partition coefficient reflects solubility in blood and predicts speed of onset/offset (kinetics).
- Oil:gas partition coefficient reflects lipid solubility and correlates with potency (lower MAC) via Meyer–Overton.
What patient factors can alter blood:gas partition coefficient and do they matter clinically?
Be honest: many effects are small; physiology often dominates.
- Temperature: increased temperature decreases solubility → lowers λB:G (modest clinical effect).
- Haematocrit: may change solubility depending on RBC affinity; usually modest effect compared with cardiac output/ventilation.
- Plasma proteins/lipids: increased lipid content may increase solubility for lipophilic agents; limited routine impact.
Past-style calculation/interpretation: ‘If an agent has a blood:gas partition coefficient of 2.0, what does that mean at equilibrium?’
They want the ratio interpretation at equal partial pressure.
- At equilibrium with equal partial pressures in blood and alveolar gas, the concentration in blood is 2 times the concentration in alveolar gas.
- This implies relatively high blood solubility and therefore greater uptake and slower FA/FI rise compared with an agent with λB:G < 1.
How would you explain to an examiner why nitrous oxide has a low blood:gas coefficient but is not always ‘fast’ in practice?
This tests that you can separate solubility from other practical constraints.
- Low λB:G supports rapid FA rise, but achievable anaesthetic depth is limited by potency (high MAC ~105%), so it cannot produce surgical anaesthesia alone at 1 atm.
- Speed of achieving a clinical endpoint also depends on delivered concentration, circuit dynamics, ventilation, and concomitant agents.
0 comments
Please log in to leave a comment.